Antonio Di Stasi, MD

I received my M.D. degree from the University of Modena in Italy, and received internal medicine and medical oncology training at the university of Milan, in Italy, where I focused on the management of hematologic malignancies and hematopoietic stem cell transplantation. Following my fellowship, I joined the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston, TX) for post-doctoral studies, where I completed the pre-clinical validation of an immunotherapy protocol for the treatment of relapsed Hodgkin lymphoma, and the clinical validation of a novel suicide gene safety switch for graft-versus-host-disease occurring after donor lymphocyte infusion. Afterwards, I underwent ECFMG certification and moved to the University of Texas MD Anderson Cancer Center for Bone Marrow Transplantation fellowship and clinical research, especially regarding myelodysplastic syndromes, acute myeloid leukemia, and haploidentical hematopoietic stem cell transplantation. My interest is to provide clinical care to patients with hematological malignancies, myelodysplastic syndromes, acute leukemias and lymphomas while being directly involved in laboratory research as well. My passion is to dedicate myself to the discovery of novel immunotherapy strategies for disease eradication and conditioning to a hematopoietic stem cell transplantation, as well as strategies to control the toxicities of those novel forms of treatment.